The companies say the drug, now in late-stage clinical trials, could be more effective for pain treatment than opioids—a dangerous category of pain killers that includes hydrocodone, morphine and fentanyl—without the abuse potential of such medications.
The Indiana Department of Insurance has yet to approve the insurers’ proposed higher rates, which will be for those buying individual plans on the Affordable Care Act marketplace next year.
Two Indianapolis-based health insurers are pulling out of Indiana’s insurance exchanges next year, citing growing uncertainty over the future of the Affordable Care Act. Together, they represent about 77,000 members who now must find other plans.
The feed-corn product, called Enlist, could represent the largest product launch in Dow Ag’s history, but environmentalists say they will fight to ban the companion herbicide.
Q&A with Rajeshwar “Raj” Rao, Indiana Municipal Power Agency: “Municipal power companies are your next-door neighbors. When you lose the lights, they lose the lights, too.”
Indiana hospitals are bracing for congressional action that could mean deep cuts in Medicaid, which funds the state’s popular health insurance program for low-income adults.
Medical office buildings, traditionally a low-key sector of the real-estate market, are getting plenty of attention these days, with recent big-dollar deals from Indianapolis players Duke Realty and Cornerstone Cos.
An embattled industry is pushing back against complaints of high drug prices, constant drug advertising and companies that don’t invest enough in research. Here’s a Q&A with Stephen Ubl, CEO of the industry’s trade group.
Just weeks after abandoning its proposed $48 billion merger with rival Cigna Corp., the Indianapolis-based health insurer is looking for its next deal. But this time, it is likely to be much smaller.
Around Indiana, hospitals are doubling down on the lofty goal of patient satisfaction. Some, like IU Health, are hiring managers to oversee various aspects of the patient experience, from registration to discharge.
The West Lafayette-based biotech firm once was seen as a rising star with a pipeline that could save cancer patients. Now, 20 years after its founding, without a single launch, it is laying off 40 percent of its workforce.
The first case against Bloomington-based Cook Group from patients who say the company’s blood-clot filters malfunctioned is headed for trial this fall in Indianapolis.
Most of the cuts this summer will come from the hospital system’s billing operations in Indianapolis.
Rice, 52, who had been the company's top finance officer since 2006, is one of the most powerful black executives in corporate America. He had been widely considered a leading candidate to succeed CEO John Lechleiter, but that position went to fellow Lilly executive Dave Ricks.
The state is asking vendors to submit bid packages by June 12 for a drug whose price has spiked in recent years.
Indiana’s Management Performance Hub is organizing and analyzing data to help state agencies make better decisions about fighting the opioid scourge and other systemic problems.
Roche Group is rolling out a new blood-glucose meter and a savings program for test strips, which it says it will make diabetes care more affordable.
Leigh Ann Pusey will join Eli Lilly and Co. next month as senior vice president for corporate affairs and communications.
The privately held company operates 32 clinics for employers in Indianapolis, Chicago, Nashville and other cities. The new funds will allow it to expand and invest in data, marketing and business development.
The proposed $48 billion merger of Anthem and Cigna kept Wall Street experts guessing for months.
